The genetic liabilities to elevated blood pressure and to severe COVID-19 intertwine, and among them, the immune-regulating receptors CCR1/CCR5 and IL10RB signaling pathway are highlighted in the common effective tissue of the lung. This evidence concerns the gene CCR5 and COVID-19.